[download_button]
Recently, IBM briefed Chilmark Research on its integration activities regarding its two acquisitions, Explorys and Phytel. The intention of the briefing was to show how these two solutions might work in the future along with their current state of their functionality. It did not address the recent Merge acquisition, any of the previous acquisitions IBM made (e.g., Curam, Initiate), the recent partnerships IBM Watson Health has signed, or how the cognitive capabilities with Watson technologies may be folded into the combined Phytel and Explorys offering in the future.
[download_anchor]
[salesforce form=”1″]
0 Comments